ArticleBreast cancer research and treatment2019

Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention.

Katherine R Walter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.